UBS AM’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26M Buy
143,425
+8,854
+7% +$203K ﹤0.01% 1831
2026
Q1
$3.14M Buy
134,571
+10,616
+9% +$229K ﹤0.01% 1816
2025
Q4
$2.48M Buy
123,955
+15,685
+14% +$306K ﹤0.01% 1801
2025
Q3
$1.98M Sell
108,270
-104,234
-49% -$2.03M ﹤0.01% 1757
2025
Q2
$4.27M Buy
212,504
+41,388
+24% +$796K ﹤0.01% 1787
2025
Q1
$3.1M Buy
171,116
+30,792
+22% +$552K ﹤0.01% 1799
2024
Q4
$2.43M Buy
140,324
+8,875
+7% +$170K ﹤0.01% 1950
2024
Q3
$2.54M Sell
131,449
-22,961
-15% -$423K ﹤0.01% 1920
2024
Q2
$2.53M Buy
154,410
+109,366
+243% +$1.7M ﹤0.01% 1873
2024
Q1
$686K Sell
45,044
-12
-0% -$188 ﹤0.01% 2186
2023
Q4
$723K Sell
45,056
-24,602
-35% -$344K ﹤0.01% 2190
2023
Q3
$905K Sell
69,658
-5,022
-7% -$65.2K ﹤0.01% 2005
2023
Q2
$840K Hold
74,680
﹤0.01% 2083
2023
Q1
$840K Buy
74,680
+9,690
+15% +$118K ﹤0.01% 2083
2022
Q4
$861K Buy
64,990
+8,023
+14% +$105K ﹤0.01% 1917
2022
Q3
$661K Sell
56,967
-10,673
-16% -$146K ﹤0.01% 2204
2022
Q2
$998K Buy
67,640
+7,282
+12% +$119K ﹤0.01% 1965
2022
Q1
$1.17M Hold
60,358
﹤0.01% 2057
2021
Q4
$1.04M Buy
60,358
+13,693
+29% +$233K ﹤0.01% 2193
2021
Q3
$780K Buy
46,665
+2,049
+5% +$30.7K ﹤0.01% 2288
2021
Q2
$598K Sell
44,616
-7,471
-14% -$93.5K ﹤0.01% 2461
2021
Q1
$622K Sell
52,087
-37,935
-42% -$459K ﹤0.01% 2306
2020
Q4
$1.12M Hold
90,022
﹤0.01% 1932
2020
Q3
$941K Buy
90,022
+24,154
+37% +$307K ﹤0.01% 1867
2020
Q2
$921K Sell
65,868
-14,189
-18% -$193K ﹤0.01% 1845
2020
Q1
$941K Buy
80,057
+7,737
+11% +$102K ﹤0.01% 1718
2019
Q4
$1.02M Sell
72,320
-8,133
-10% -$99.8K ﹤0.01% 1903
2019
Q3
$848K Buy
80,453
+21,414
+36% +$256K ﹤0.01% 2027
2019
Q2
$860K Buy
59,039
+3,786
+7% +$53.7K ﹤0.01% 1956
2019
Q1
$775K Sell
55,253
-1,514
-3% -$24.5K ﹤0.01% 1917
2018
Q4
$991K Buy
56,767
+11,140
+24% +$181K ﹤0.01% 1763
2018
Q3
$695K Hold
45,627
﹤0.01% 1947
2018
Q2
$630K Hold
45,627
﹤0.01% 1996
2018
Q1
$761K Buy
45,627
+8,200
+22% +$127K ﹤0.01% 1869
2017
Q4
$531K Buy
37,427
+2,086
+6% +$27.8K ﹤0.01% 1947
2017
Q3
$499K Buy
35,341
+7,639
+28% +$101K ﹤0.01% 1947
2017
Q2
$355K Sell
27,702
-11,432
-29% -$143K ﹤0.01% 1968
2017
Q1
$541K Buy
39,134
+12,650
+48% +$149K ﹤0.01% 1842
2016
Q4
$283K Sell
26,484
-21,000
-44% -$220K ﹤0.01% 1966
2016
Q3
$522K Hold
47,484
﹤0.01% 1960
2016
Q2
$500K Buy
47,484
+11,487
+32% +$136K ﹤0.01% 1951
2016
Q1
$453K Sell
35,997
-11,900
-25% -$131K ﹤0.01% 1976
2015
Q4
$505K Sell
47,897
-14,252
-23% -$131K ﹤0.01% 2048
2015
Q3
$446K Buy
62,149
+24,852
+67% +$338K ﹤0.01% 2080
2015
Q2
$674K Buy
37,297
+5,400
+17% +$92.7K ﹤0.01% 1885
2015
Q1
$501K Buy
31,897
+1,700
+6% +$25.7K ﹤0.01% 1980
2014
Q4
$427K Sell
30,197
-367,700
-92% -$5.53M ﹤0.01% 2026
2014
Q3
$6.8M Sell
397,897
-372,500
-48% -$8.56M 0.01% 966
2014
Q2
$22.9M Sell
770,397
-158,488
-17% -$3.8M 0.02% 641
2014
Q1
$23.2M Buy
928,885
+139,116
+18% +$4.07M 0.02% 625
2013
Q4
$22.7M Sell
789,769
-4,343
-0.5% -$127K 0.03% 601
2013
Q3
$26.2M Buy
794,112
+99,652
+14% +$3.1M 0.03% 520
2013
Q2
$21.6M Buy
+694,460
New +$18.6M 0.03% 547

Other funds holding INVA

UBS AM's INVA Position: Q2 2026 in Review

UBS AM increased its Innoviva (INVA) stake by 6.6% in Q2 2026, buying an estimated $203K and bringing the position to 143,425 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

UBS AM first reported a position in INVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.2M in Q3 2013. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • UBS AM held 143,425 shares of Innoviva worth $3.26M as of Q2 2026.
  • UBS AM bought 8,854 Innoviva shares in Q2 2026, an estimated $203K.
  • Innoviva made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1831 holding.
  • UBS AM first reported a position in Innoviva in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Innoviva position peaked at $26.2M in Q3 2013.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.